lamotrigine

Generic: lamotrigine

Labeler: dr.reddy's laboratories limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lamotrigine
Generic Name lamotrigine
Labeler dr.reddy's laboratories limited
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

lamotrigine 50 mg/1

Manufacturer
Dr.Reddy's Laboratories Limited

Identifiers & Regulatory

Product NDC 55111-718
Product ID 55111-718_236437dc-fce9-b140-992c-b7822562eee5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202383
Listing Expiration 2027-12-31
Marketing Start 2013-06-20

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc] mood stabilizer [epc]
Mechanism of Action
organic cation transporter 2 inhibitors [moa] dihydrofolate reductase inhibitors [moa]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55111718
Hyphenated Format 55111-718

Supplemental Identifiers

RxCUI
850087 850091 900156 900164 1098608 1146690
UNII
U3H27498KS
NUI
N0000175753 N0000008486 N0000175751 N0000187061 N0000000191

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lamotrigine (source: ndc)
Generic Name lamotrigine (source: ndc)
Application Number ANDA202383 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-718-05)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-718-30)
source: ndc

Packages (2)

55111-718-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-718-05) 55111-718-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-718-30)

Ingredients (1)

lamotrigine (50 mg/1)

Linked Drug Pages (1)

Lamotrigine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "236437dc-fce9-b140-992c-b7822562eee5", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["850087", "850091", "900156", "900164", "1098608", "1146690"], "spl_set_id": ["a69542ea-5b6f-15c1-9e7a-90ac839971d3"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Dr.Reddy's Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-718-05)", "package_ndc": "55111-718-05", "marketing_start_date": "20130620"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (55111-718-30)", "package_ndc": "55111-718-30", "marketing_start_date": "20130620"}], "brand_name": "Lamotrigine", "product_id": "55111-718_236437dc-fce9-b140-992c-b7822562eee5", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "55111-718", "generic_name": "Lamotrigine", "labeler_name": "Dr.Reddy's Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "50 mg/1"}], "application_number": "ANDA202383", "marketing_category": "ANDA", "marketing_start_date": "20130620", "listing_expiration_date": "20271231"}